Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 4/2007

01.04.2007

Impact of Solitary Involved Lymph Node on Outcome in Localized Cancer of the Esophagus and Esophagogastric Junction

verfasst von: James M. O’Riordan, Suzanne Rowley, James O. Murphy, Narayasami Ravi, Patrick J. Byrne, John V. Reynolds

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 4/2007

Einloggen, um Zugang zu erhalten

Abstract

Node-positive esophageal cancer is associated with a dismal prognosis. The impact of a solitary involved node, however, is unclear, and this study examined the implications of a solitary node compared with greater nodal involvement and node-negative disease. The clinical and pathologic details of 604 patients were entered prospectively into a database from1993 and 2005. Four pathologic groups were analyzed: node-negative, one lymph node positive, two or three lymph nodes positive, and greater than three lymph nodes positive. Three hundred and fifteen patients (52%) were node-positive and 289 were node-negative. The median survival was 26 months in the node-negative group. Patients (n = 84) who had one node positive had a median survival of 16 months (p = 0.03 vs node-negative). Eighty-four patients who had two or three nodes positive had a median survival of 11 months compared with a median survival of 8 months in the 146 patients who had greater than three nodes positive (p = 0.01). The survival of patients with one node positive [number of nodes (N) = 1] was also significantly greater than the survival of patients with 2–3 nodes positive (N = 2–3) (p = 0.049) and greater than three nodes positive (p < 0001). The presence of a solitary involved lymph node has a negative impact on survival compared with node-negative disease, but it is associated with significantly improved overall survival compared with all other nodal groups.
Literatur
1.
Zurück zum Zitat Roder JD, Busch R, Stein HJ, et al. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the esophagus. Br J Surg. 1994;81:410–413.PubMedCrossRef Roder JD, Busch R, Stein HJ, et al. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the esophagus. Br J Surg. 1994;81:410–413.PubMedCrossRef
2.
Zurück zum Zitat HulscherJB, Van Sandick JW, De Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662–1669.PubMedCrossRef HulscherJB, Van Sandick JW, De Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662–1669.PubMedCrossRef
3.
Zurück zum Zitat Ito H, Clancy TE, Osteen RT, et al. Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg. 2004;199: 880–886.PubMedCrossRef Ito H, Clancy TE, Osteen RT, et al. Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg. 2004;199: 880–886.PubMedCrossRef
4.
Zurück zum Zitat Altorki N, Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg. 2001;234:581–587.PubMedCrossRef Altorki N, Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg. 2001;234:581–587.PubMedCrossRef
5.
Zurück zum Zitat Hagen JA, DeMeester SR, Peters JH, et al. Curative resection for esophageal adenocarcinoma: Analysis of 100 en bloc esophagectomies. Ann Surg. 2001;234:520–531.PubMedCrossRef Hagen JA, DeMeester SR, Peters JH, et al. Curative resection for esophageal adenocarcinoma: Analysis of 100 en bloc esophagectomies. Ann Surg. 2001;234:520–531.PubMedCrossRef
6.
Zurück zum Zitat Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227:645–651.PubMedCrossRef Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227:645–651.PubMedCrossRef
7.
Zurück zum Zitat Lamb PJ, Griffin SM, Burt AD, et al. Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. Br J Surg. 2005;92:60–67.PubMedCrossRef Lamb PJ, Griffin SM, Burt AD, et al. Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. Br J Surg. 2005;92:60–67.PubMedCrossRef
8.
Zurück zum Zitat Burian M, Stein HJ, Sendler A, et al. Sentinel node detection in Barrett’s and cardia cancer. Ann Surg Oncol. 2004;11:255S–258S.PubMed Burian M, Stein HJ, Sendler A, et al. Sentinel node detection in Barrett’s and cardia cancer. Ann Surg Oncol. 2004;11:255S–258S.PubMed
9.
Zurück zum Zitat Luketich JD, Alvero-Rivera M, Buenaventura PO, et al. Minimally invasive esophagectomy: Outcomes in 222 patients. Ann Surg. 2003;238:486–494.PubMed Luketich JD, Alvero-Rivera M, Buenaventura PO, et al. Minimally invasive esophagectomy: Outcomes in 222 patients. Ann Surg. 2003;238:486–494.PubMed
10.
Zurück zum Zitat Walsh TN, Noonan N, Hollywood D, Kelly A, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462–467.PubMedCrossRef Walsh TN, Noonan N, Hollywood D, Kelly A, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462–467.PubMedCrossRef
11.
Zurück zum Zitat Digestive system: The esophagus. In: AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott, Williams and Wilkins, 1997, pp. 65–67. Digestive system: The esophagus. In: AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott, Williams and Wilkins, 1997, pp. 65–67.
12.
Zurück zum Zitat Cox D. Regression models and life tables. J R Stat Soc. 1972;34:197–219. Cox D. Regression models and life tables. J R Stat Soc. 1972;34:197–219.
13.
Zurück zum Zitat Siewert JR, Feith M, Werner M, et al. Adenocarcinoma of the esophagogastric junction: Results of surgical therapy based on anatomical/topographical classification in 1,002 consecutive patients. Ann Surg. 2000;232:353–361.CrossRef Siewert JR, Feith M, Werner M, et al. Adenocarcinoma of the esophagogastric junction: Results of surgical therapy based on anatomical/topographical classification in 1,002 consecutive patients. Ann Surg. 2000;232:353–361.CrossRef
14.
Zurück zum Zitat Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer. 2000;88:921–932.PubMedCrossRef Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer. 2000;88:921–932.PubMedCrossRef
15.
Zurück zum Zitat Dresner SM, Wayman J, Shenfine J, et al. Pattern of recurrence following subtotal oesophagectomy with two field lymphadenectomy. Br J Surg. 2000;87:362–373.CrossRef Dresner SM, Wayman J, Shenfine J, et al. Pattern of recurrence following subtotal oesophagectomy with two field lymphadenectomy. Br J Surg. 2000;87:362–373.CrossRef
16.
Zurück zum Zitat Akiyama H, Tsurumara M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 1994;220:364–372.PubMedCrossRef Akiyama H, Tsurumara M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 1994;220:364–372.PubMedCrossRef
17.
Zurück zum Zitat Eloubeidi MA, Desmond R. Prognostic factors for the survival of patients with esophageal cancer in the US. Cancer. 2002;95:1434–1443.PubMedCrossRef Eloubeidi MA, Desmond R. Prognostic factors for the survival of patients with esophageal cancer in the US. Cancer. 2002;95:1434–1443.PubMedCrossRef
18.
Zurück zum Zitat Hsu CP, Chen CY, Hsia JY, Shai SE. Prediction of prognosis by the extent of lymph node involvement in squamus cell carcinoma of the thoracic esophagus. Eur J Cardio-thorac Surg. 2001;19:10–13.CrossRef Hsu CP, Chen CY, Hsia JY, Shai SE. Prediction of prognosis by the extent of lymph node involvement in squamus cell carcinoma of the thoracic esophagus. Eur J Cardio-thorac Surg. 2001;19:10–13.CrossRef
19.
Zurück zum Zitat Gu Y, Swisher SG, Ajani JA, Correa AM. et al. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer. 2006;106:1017–1025.PubMedCrossRef Gu Y, Swisher SG, Ajani JA, Correa AM. et al. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer. 2006;106:1017–1025.PubMedCrossRef
Metadaten
Titel
Impact of Solitary Involved Lymph Node on Outcome in Localized Cancer of the Esophagus and Esophagogastric Junction
verfasst von
James M. O’Riordan
Suzanne Rowley
James O. Murphy
Narayasami Ravi
Patrick J. Byrne
John V. Reynolds
Publikationsdatum
01.04.2007
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 4/2007
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-006-0027-5

Weitere Artikel der Ausgabe 4/2007

Journal of Gastrointestinal Surgery 4/2007 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.